Skip to content

News Health

Health News, Tips, and More

Menu
  • Disclaimer
  • Related Sites
Menu

A new therapeutic intervention for Pancreatic Ductal Adenocarcinoma

Posted on June 28, 2010June 27, 2010 by News Health

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tumor with a very poor prognosis. Hypoxia-inducible transcription factor-1α (HIF-1α) is involved in malignant progression in many solid tumors, including PDAC, upregulation of HIF-1α accelerates PDAC progression, but the exact regulatory mechanisms of HIF-1αin PDAC has not been unequivocally addressed. Recently, an increasing number of studies reported that toll-like receptors (TLRs) were upregulated in epithelial malignancies and involved in tumor progression, but whether TLRs, such as TLR4, is expressed on PDAC cells remains unknown. In immune-related cells, TLR signal pathway may induce expression of HIF-1α, but it is also still unclear whether there exists some association between TLR4 and HIF-1α in tumor microenviroment, such as PDAC.

A research article published in the World Journal of Gastroenterology addresses this issue. The research team led by He-Shui Wu, MD, from Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, used real time polymerase chain reaction and immunohistochemistry, to detect TLR4, NF-κB p65 and HIF-1α expression in 65 cases of PDAC tissues and 38 cases of corresponding adjacent tissues.

Their study revealed that TLR4, NF-κB p65 and HIF-1α were overexpressed in PDAC. The expression of TLR4 and HIF-1α was associated with tumor size, lymph node metastasis, venous invasion and pathological stage. Furthermore, the expression of TLR4 was positively correlated with expression of HIF-1α. Thus, TLR4 may be a novel marker for the progression and prognosis of PDAC, and may provide a new strategy for therapeutic intervention in the treatment of patients with PDAC in the future.

Based on these results and previous reports, the authors speculated that active TLR4 signal pathway may be partly involved in up-regulating HIF-1α in PDAC tumor microenviroment via NF-κB pathway, and promoted progression of PDAC. These results demonstrated a new view of molecules involved in regulatory mechanism of HIF-1α and thus may provide new therapeutic targets for PDAC.

source:   http://www.medicalnewstoday.com/articles/193024.php

1 thought on “A new therapeutic intervention for Pancreatic Ductal Adenocarcinoma”

  1. Carroll B. Merriman says:
    April 6, 2011 at 3:00 am

    I couldn’t understand some parts of this article, but it sounds interesting

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Signs of Opiate Addiction to Look for in a Loved One
  • Why Hospital Waste Disposal Services Are Crucial for the Health and Safety of Patients
  • How Much Does TMS Cost?
  • The Basics of Health Insurance
  • Local Resources to Help You Discover What Is Health Protection
  • Accident Resources After Being in a Car Wreck
  • How Summer Camp Can Improve Mental Health in Children
  • Choose the Right Volleyball Equipment With These Tips
  • Resources to Help Families Be Healthy and Smart
  • Answering Your Questions About Alcohol Rehab

Archives

June 2023
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« May    
© 2023 News Health | Powered by Superbs Personal Blog theme